EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation Between Pathological and MRI Radiological Tumor Responses to Neoadjuvant Chemotherapy in Non‐Luminal Breast Cancer: A Single Institution Experience

Wesal M Eldehna iD, Fawzy Elbarbry iD, Abdul Hameed Hassan iD, Rafat Abu Shakra iD, Ahmed Elaryan iD, Ola Mousa Abdelfattah Elnady iD, Elshaimaa Mohamed Mohamed iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Wesal M Eldehna und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Magnetic Resonance Imaging, Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neoadjuvant chemotherapy ( NACT ) is the standard treatment for patients with locally advanced breast cancer. In recent years, it has also been used for early‐stage triple‐negative breast cancer ( TNBC ) and human epidermal growth factor receptor 2‐positive ( HER2 + ) breast cancers.

Objectives

Our hypothesis asserts a correlation between breast radiological and pathological response post‐ NACT in non‐luminal breast cancer patients. We also aimed to determine the predictive value of MRI in predicting response in these patients. Radiologist agreement upon radiological MRI response is also highlighted in the current study.

Methods

A retrospective study to evaluate MRI 's accuracy for assessing tumor response to NACT in early and locally advanced non‐metastatic breast cancer patients in comparison with pathological assessments. We enrolled cases that were treated with neoadjuvant chemotherapy between December 2019 and November 2023.

Results

Dynamic MRI 's sensitivity to detect tumor response is 86.4%, its specificity is 96.8%, and its accuracy is 92.4%, with a significant p ‐value. So, the high correlation between measurements of residual disease detected by MRI and those detected by pathological assessment supports the use of MRI for imaging assessment during NACT . The two radiologists involved in our study were in good agreement in their assessment of radiological response (Kappa: 0.801, sensitivity: 85.7%, specificity: 93.8%, and accuracy: 90.6%).

Conclusions

The accuracy of imaging assessment by breast MRI during NACT is validated by the greater correlation between measurements of residual disease on MRI and pathology, establishing its role as the most precise imaging modality. We strongly advocate for the dependable role of MRI in monitoring breast lesions during neoadjuvant therapy, especially in non‐luminal breast cancer cases, regardless of whether they present as mass or non‐mass enhancement patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyMagnetic Resonance ImagingBreast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsTriple Negative Breast NeoplasmsHumansFemaleRetrospective StudiesMiddle AgedAdultAgedChemotherapy, AdjuvantBreastTreatment OutcomePredictive Value of Tests

Stichwörter der Autor:innen

breast cancercorrelationmagnetic resonance imagingneoadjuvant chemotherapytumor response

Autor:innen und Institutionen

  • Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Department of Oncology, International Medical Center, Jeddah, Saudi Arabia.
  • School of Pharmacy, Pacific University, Hillsboro, Oregon, USA.
  • Department of Family Medicine, International Medical Center, Jeddah, Saudi Arabia.
  • Department of Pathology and Laboratory Medicine, International Medical Center, Jeddah, Saudi Arabia.
  • Department of Medical Imaging, International Medical Center, Jeddah, Saudi Arabia.

ORCID-Profile: Wesal M Eldehna, Fawzy Elbarbry, Abdul Hameed Hassan, Rafat Abu Shakra, Ahmed Elaryan, Ola Mousa Abdelfattah Elnady, Elshaimaa Mohamed Mohamed

Zitieren

APA

Eldehna, W. M., Elbarbry, F., Hassan, A. H., Shakra, R. A., Elaryan, A., Elnady, O. M. A., & Mohamed, E. M. (2025). Correlation Between Pathological and MRI Radiological Tumor Responses to Neoadjuvant Chemotherapy in Non‐Luminal Breast Cancer: A Single Institution Experience. Cancer Reports. https://doi.org/10.1002/cnr2.70275

Vancouver

Eldehna WM, Elbarbry F, Hassan AH, Shakra RA, Elaryan A, Elnady OMA, et al. Correlation Between Pathological and MRI Radiological Tumor Responses to Neoadjuvant Chemotherapy in Non‐Luminal Breast Cancer: A Single Institution Experience. Cancer Reports. 2025. doi:10.1002/cnr2.70275

BibTeX
@article{Eldehna2025,
  author = {Eldehna, Wesal M and Elbarbry, Fawzy and Hassan, Abdul Hameed and Shakra, Rafat Abu and Elaryan, Ahmed and Elnady, Ola Mousa Abdelfattah and Mohamed, Elshaimaa Mohamed},
  title = {Correlation Between Pathological and MRI Radiological Tumor Responses to Neoadjuvant Chemotherapy in Non‐Luminal Breast Cancer: A Single Institution Experience},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70275}
}
Kostenlos starten →